Latest news with #hospitaloperator
Yahoo
5 days ago
- Business
- Yahoo
HCA Healthcare Raises Full-Year Outlook Following Quarterly Beat
HCA Healthcare (HCA) on Friday raised its full-year financial outlook as the hospital operator repor Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
6 days ago
- Business
- Bloomberg
Europe's Junk Loan Market Shows Rare Sign of Investor Fatigue
Lenders are demanding higher pricing from two European leveraged-loan borrowers, a rare sign of difficulty these days in the buoyant market for sub-investment grade debt. Pricing for a €450 million ($529 million) loan to French hospital operator Almaviva Sante has increased to 425 basis points over Euribor from an initial 375 basis points. Nursing home company DomusVi, meanwhile, has seen price talk for its €1.979 billion repricing climb to to Euribor plus 475 from guidance of 425 to 450 basis points over Euribor.
ABC News
6 days ago
- Health
- ABC News
Ramsay Health closes psychology clinics
Australia's largest private hospital operator has moved to close the majority of its psychology clinics, leaving thousands of vulnerable patients facing the prospect of being left without crucial care.
Bloomberg
09-07-2025
- Business
- Bloomberg
Hospital Operator IHH Eyes Indonesia, Vietnam for Expansion
IHH Healthcare Bhd. is looking to potential new markets Indonesia and Vietnam as the Malaysian hospital operator continues building scale to offset rising healthcare costs in the region. Indonesia is attractive, thanks to its healthcare reforms and foreign ownership relaxation, while Vietnam has emerged as a booming market, according to Chief Executive Officer Prem Kumar Nair.
Yahoo
01-07-2025
- Business
- Yahoo
Here's What to Expect From HCA Healthcare's Next Earnings Report
With a market cap of $92.2 billion, HCA Healthcare, Inc. (HCA) is the largest non-governmental operator of acute care hospitals in the United States. Through its subsidiaries, the company owns and operates a broad network of hospitals and healthcare facilities offering comprehensive inpatient, outpatient, and behavioral health services across the U.S. and in England. The Nashville, Tennessee-based company is slated to announce its fiscal Q2 2025 earnings results on Tuesday, Jul. 22. Ahead of the event, analysts are expecting HCA to report an EPS of $6.14, an increase of 11.6% from $5.50 in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in the past four quarterly reports. In Q1 2025, HCA Healthcare exceeded the consensus EPS estimate by 11.8%. Jeff Bezos Unloads $5.4B in Amazon Shares: Should You Buy or Sell AMZN Stock Now? Elon Musk's Tesla Makes History With 'First Time That a Car Has Delivered Itself to Its Owner' This Defense Stock Could Be the Next Palantir. Should You Buy It Now? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For fiscal 2025, analysts expect the hospital operator to report EPS of $25.26, up over 15% from $21.96 in fiscal 2024. Shares of HCA have returned 19.2% over the past 52 weeks, outpacing both the S&P 500 Index's ($SPX) 13.6% rise and the Health Care Select Sector SPDR Fund's (XLV) 7.5% decline over the same period. HCA Healthcare reported Q1 2025 results on Apr. 25, with EPS rising nearly 9% to $6.45, exceeding Wall Street expectations. Revenue also beat forecasts, coming in at $18.3 billion, driven by a 2.6% increase in same-facility admissions and a 4% rise in emergency room visits, reflecting sustained demand for elective and urgent care procedures. Investor confidence was further boosted as HCA reiterated its annual profit forecast of $24.05 to $25.85 per share, despite concerns over tariffs and policy uncertainty. However, the stock fell nearly 4% following the report. Analysts' consensus rating on HCA Healthcare stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 25 analysts covering the stock, 15 recommend a "Strong Buy,' two have a "Moderate Buy" rating, and eight give a "Hold" rating. This configuration is slightly less bullish than three months ago, with 16 analysts suggesting a "Strong Buy." The average analyst price target for HCA is $398.52, indicating a potential upside of just 4% from the current levels. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
